AbbVie
ABBV
#26
Rank
HK$3.109 T
Marketcap
HK$1,759
Share price
-1.15%
Change (1 day)
31.87%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : HK$1.062 Trillion

According to AbbVie's latest financial reports the company's total liabilities are HK$1.062 Trillion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

AbbVie - Total liabilities on balance sheet (from 2011 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31HK$1.023 T5.39%
2023-12-31HK$970.89 B2.26%
2022-12-31HK$949.45 B-7.12%
2021-12-31HK$1.022 T-4.08%
2020-12-31HK$1.065 T40.65%
2019-12-31HK$757.68 B42.71%
2018-12-31HK$530.91 B3.45%
2017-12-31HK$513.22 B7.68%
2016-12-31HK$476.61 B25.23%
2015-12-31HK$380.59 B90.4%
2014-12-31HK$199.89 B4.34%
2013-12-31HK$191.57 B4.53%
2012-12-31HK$183.27 B210.94%
2011-12-31HK$58.94 B39.44%
2010-12-31HK$42.27 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
HK$899.84 B-15.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$609.22 B-42.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$708.79 B-33.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$626.60 B-41.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$288.52 B-72.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$85.59 B-91.94%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$476.90 B-55.10%๐Ÿ‡ฌ๐Ÿ‡ง UK
AstraZeneca
AZN
HK$532.93 B-49.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
HK$9.82 B-99.08%๐Ÿ‡บ๐Ÿ‡ธ USA